Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 16, 2021Frontiers in PharmacologyOpen Access

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis

View Full Paper
Ask AI
Bookmark
Share

Authors

Shanshan LiShanshan LiPreventive CardiologyQSQian SunCentral China Normal UniversityMHMeng-Ru HuaZhejiang Chinese Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2021) studied this question.

synapsesocial.com/papers/6a757e52ef3d015f2ddd750dhttps://doi.org/10.3389/fphar.2021.719880
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease2017 · 162 citations
  2. 2A unique type of GSK-3 inhibitor brings new opportunities to the clinic2016 · 77 citations
  3. 3Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer2012 · 395 citations
  4. 4Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis2010 · 462 citations
  5. 5PAI-1 modulates cell migration in a LRP1-dependent manner via β-catenin and ERK1/22015 · 32 citations